The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2013

Filed:

Apr. 21, 2011
Applicants:

Genesis M. Bacani, San Diego, CA (US);

Scott D. Bembenek, San Diego, CA (US);

Wendy Eccles, San Diego, CA (US);

James P. Edwards, San Diego, CA (US);

Matthew T. Epperson, San Diego, CA (US);

Laurent Gomez, San Diego, CA (US);

Cheryl A. Grice, Carlsbad, CA (US);

Aaron M. Kearney, Lakeside, CA (US);

Adrienne M. Landry-bayle, Carlsbad, CA (US);

Alice Lee-dutra, San Diego, CA (US);

Kelly J. Mcclure, Ramona, CA (US);

Taraneh Mirzadegan, San Diego, CA (US);

Alexandro Santillán, Jr., San Diego, CA (US);

Inventors:

Genesis M. Bacani, San Diego, CA (US);

Scott D. Bembenek, San Diego, CA (US);

Wendy Eccles, San Diego, CA (US);

James P. Edwards, San Diego, CA (US);

Matthew T. Epperson, San Diego, CA (US);

Laurent Gomez, San Diego, CA (US);

Cheryl A. Grice, Carlsbad, CA (US);

Aaron M. Kearney, Lakeside, CA (US);

Adrienne M. Landry-Bayle, Carlsbad, CA (US);

Alice Lee-Dutra, San Diego, CA (US);

Kelly J. McClure, Ramona, CA (US);

Taraneh Mirzadegan, San Diego, CA (US);

Alexandro Santillán, Jr., San Diego, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/425 (2006.01);
U.S. Cl.
CPC ...
Abstract

Aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and the pharmaceutical compositions for leukotriene Ahydrolase (LTAH or LTA4H) modulation and for the treatment of disease states, disorders, and conditions mediated by LTAH activity, such as allergy, asthma, autoimmune diseases, pruritis, inflammatory bowel disease, ulcerative colitis, and cardiovascular disease, including atherosclerosis and prevention of myocardial infarction.


Find Patent Forward Citations

Loading…